Life Expectancy after Liver Transplantation for NASH

Area of Science:

• Hepatology
• Transplantation Medicine
• Public Health

Background:

• Non-Alcoholic Steatohepatitis (NASH) is a growing cause of liver transplantation globally.
• Understanding recipient life expectancy is crucial for allocating scarce donor organs.

Purpose of the Study:

• To calculate life expectancies for NASH patients post-liver transplant.
• To stratify life expectancy by key risk factors.
• To examine survival trends over time.

Main Methods:

• Analysis of 6635 NASH liver transplant recipients from the US OPTN database (2002-2018).
• Utilized Cox proportional hazards regression and life table methods.
• Stratified survival by pre- and post-transplant factors.

Main Results:

• Key survival factors include age, diabetes, hepatic encephalopathy, pre-transplant dialysis, employment status, hospitalization, ventilator support, and length of stay.
• Survival improved by approximately 4.5% annually in the first year post-transplant.
• No significant survival improvement was observed after the first post-transplant year.

Conclusions:

• NASH liver transplant recipients have substantially reduced life expectancy compared to the general population.
• Prognosis varies based on recipient age, medical comorbidities, and post-transplant course.
• While early post-transplant survival has improved, long-term outcomes require further investigation.